FTSE 100 Live: Stocks slide as oil spikes after US launches 80 strikes on Iran

FTSE 100 is set to open lower after US forces launched strikes on more than 80 targets in Iran, escalating tensions and pushing Brent crude up 3.3% to $76.64. Early trading shows declines across AstraZeneca, Rolls-Royce, GSK, NatWest, LSEG and RELX, while BP rises 2.3%. Jet2 announced a £250m buyback; Vistry warned of a first-half loss.

Original reporting
Published Jul 8, 2026, 7:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 7:34 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$VTS
Bearish
high confidence
Mentioned
$VTS
Relevance
5/10
alphai data visualization · based on proactiveinvestors.co.uk
Decision brief

The 30-second read

$VTSBearishMed
01

Why it matters

The newest actionable company-specific items are Jet2’s buyback and Vistry’s profit warning. The rest of the article is primarily macro and index-level positioning tied to oil and geopolitical escalation.

02

Market read

Traders can act on two company-specific disclosures (buyback, profit warning) while also managing broader risk from oil-driven macro repricing at the open.

03

What to watch

The article also notes semiconductor weakness in the prior US session and a specific FTSE constituent move (BP up), which may create dispersion rather than a uniform selloff.

Relevance 5/10Novelty 5/10Timing: pre-open in London, as oil jumps after US strikes on Iran and FTSE futures fall

Background

The piece frames a UK market open around US strikes on Iran, with oil jumping and geopolitical risk concerns resurfacing.

Company-level read

Ticker impact

$VTSBearishHigh confidence
Context

Vistry warned it expects a first-half loss before tax of about £30 million, citing a £50 million hit from accelerated debt and reshaping actions.

Expected impact

Downward pressure likely, with elevated volatility until HY results and CEO review details clarify the restructuring path.

Evidence & confidence

The article discloses a concrete loss estimate, the magnitude of one-off impacts, and management changes (CFO leaving, CEO review), which are direct drivers for traders.

Market effects

Oil spike and Middle East escalation raise near-term inflation and stagflation fears, pressuring rate-sensitive and broad cyclicals while supporting some energy names.

UK-focused risk-off at the open, with FTSE 100 futures down and European stocks set to open lower.

US-Iran escalation can spill into global energy pricing, rates, and risk appetite across major equity indices.

Counterpoint

Energy-price strength can be partially offset by expectations of policy response or hedging demand, limiting equity downside beyond the initial shock.

Key entities

  • Jet2

    Announced a £250 million share buyback and reported operating profit at the top of its guided range.

  • Vistry Group

    Issued a first-half profit warning, expecting a pre-tax loss and detailing restructuring-related impacts.

  • Iran

    US launched strikes on more than 80 targets, escalating tensions and affecting oil prices.

Related articles

$VTSMed

Vitesse Energy Q2 Earnings Call Highlights

Vitesse Energy (NYSE:VTS) reported Q2 call highlights. Management said unrealized hedging gains are non-cash tied to forward oil prices, with cumulative realized hedge loss under 1% of revenue since its spin-off. Hedge coverage extends into 2029. 2026 production guidance narrowed to 16,300-17,200 BOE/d; capex raised to $65-$80M. Debt was $158.5M and liquidity about $117M.

$VTSMed

Vitesse Energy (NYSE:VTS) Reports Strong Q2 CY2026

Vitesse Energy (NYSE:VTS) reported Q2 CY2026 results. Revenue rose 11.3% year on year to $91 million, exceeding Wall Street estimates by 8.2%. GAAP profit was $0.77 per share above consensus. Free cash flow was $16.34 million (18% margin). The stock fell 1.8% to $15.22 after the release.

$VTSMed

Vitesse Energy, Inc. (VTS): Results of Operations and Financial Condition

Vitesse Energy, Inc. (VTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. VITESSE ENERGY ANNOUNCES SECOND QUARTER 2026 RESULTS GREENWOOD VILLAGE, Colo. – August 3, 2026 – Vitesse Energy, Inc. (NYSE: VTS) (“we,” “our,” “Vitesse,” or the “Company”) today reported the Company’s second quarter 2026 financial and operating results. SECOND QUARTER 2026 HIGHL

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.